Oncolytics Biotech Inc. has been granted patent for extracting virus from cell culture
Oncolytics Biotech Inc. has been granted U.S. Patent 7,186,542 entitled "Method of Extracting Virus from Cell Culture." The claims describe a method of producing infectious reovirus that allows for the removal of cell debris by filtration and concentration of the filtrate.
"This patent expands on similar manufacturing patents secured by the Company," said Dr. Matt Coffey, Chief Scientific Officer of Oncolytics.
Most read news
Other news from the department research and development

Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.